In recognition of May’s Asthma Awareness Month, this episode highlights our conversation with Dr. Juan Carlos Cardet at University of South Florida and Dr. Elliot Israel at Brigham and Women’s Hospital about the most common respiratory disease in the U.S. It provides a deep dive into the guideline-supported SMART strategy, role of COVID-19 in current asthma risks, and research into the medical and financial impacts of asthma on the U.S. patient population.

0:16 The Discovery of Asthma

2:12 Introducing Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH

3:20 Defining the SMART asthma strategy

5:46 The slow rollout of SMART

10:19 The strategy and findings of the PREPARE trial

21:41 How to initiate patient-activated reliever-triggered inhaled corticosteroid

25:15 The effect of COVID-19 on real-world asthma trials

27:40 How to lessen the disparities of asthma

31:14 Outro

For additional news and insights, visit us at HCPLive.com and Lung.org.